Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RWJ 58259

Known as: RWJ-58259 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A novel class of bivalent ligands targeting putative protease-activated receptor (PAR) heteromers has been prepared based upon… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2018
2018
Several classes of ligands for Protease-Activated Receptors (PARs) have shown impressive anti-inflammatory and cytoprotective… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
2016
2016
The discontinuation of PAR-1 antagonist RWJ-58259 beyond use as a biological probe is most likely due to it's short half-life in… Expand
  • figure 1
  • figure 2
  • table 1
2015
2015
Accumulated evidences indicate intestinal lesions play an important role in the pathogenesis of heatstroke. However, the… Expand
2012
2012
By applying a diversity oriented synthesis strategy for the search of new antagonists of the thrombin receptor PAR1, a series of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
2009
2009
A significant improvement on the synthesis of the PAR-1 antagonist RWJ-58259 is described, which involves a base-related two-fold… Expand
  • table 1
Review
2003
Review
2003
Protease activated receptor-1 (PAR-1) is a key mediator of the cellular actions of alpha-thrombin. Thus, antagonism of this… Expand
Highly Cited
2003
Highly Cited
2003
Although it is well recognized that human platelet responses to α-thrombin are mediated by the protease-activated receptors PAR-1… Expand
  • figure 6
Review
2003
Review
2003
Protease-activated receptors (PARs) represent a unique family of seven-transmembrane G-protein-coupled receptors, which are… Expand
Highly Cited
2001
Highly Cited
2001
Human platelets possess two distinct thrombin-activated receptors, PAR-1 (protease-activated receptor-1) and PAR-4, whereas human… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4